Skip to main content
. 2020 Sep 28;71(1):158–167. doi: 10.1007/s12020-020-02501-3

Fig. 4.

Fig. 4

First IGF-I ≤ ULN - Cumulative incidence in patients under monotherapy or primary bitherapy (PEG added to SA). Population: patients with IGF-I > ULN at baseline and with at least one post-baseline IGF-I